Intranasal administration of insulin to humans
- PMID: 1879306
- DOI: 10.1016/0168-8227(91)90083-p
Intranasal administration of insulin to humans
Abstract
The purpose of this review is to summarize the information and experience at present available on the intranasal administration of insulin to human subjects and to describe some of the anatomical, physiological, pharmaceutical and technological factors which can affect the absorption of insulin. An overview is given of those absorption promoters which have been used in clinical insulin studies, and the possible absorption-promoting mechanisms are discussed. This review shows that the nasal route offers a promising alternative to parenteral administration. The easier administration and the acceptance by the patients is encouraging the development of new intranasal insulin preparations.
Similar articles
-
New strategies to improve the intranasal absorption of insulin.Drug Discov Today. 2010 Jun;15(11-12):416-27. doi: 10.1016/j.drudis.2010.03.011. Epub 2010 Mar 30. Drug Discov Today. 2010. PMID: 20359545 Review.
-
Alternative routes of insulin delivery.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Oct;34(10):933-48. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009. PMID: 19893243 Review.
-
Current Therapeutic Strategy in the Nasal Delivery of Insulin: Recent Advances and Future Directions.Curr Pharm Biotechnol. 2018;19(5):400-415. doi: 10.2174/1389201019666180619145429. Curr Pharm Biotechnol. 2018. PMID: 29921203 Review.
-
Advances in treating diabetes with aerosolized insulin.Diabetes Technol Ther. 2002;4(4):515-8. doi: 10.1089/152091502760306607. Diabetes Technol Ther. 2002. PMID: 12396746 Review. No abstract available.
-
Intranasal insulin administration: a method for dissociating central and peripheral effects of insulin.Drugs Today (Barc). 2006 Nov;42(11):729-39. doi: 10.1358/dot.2006.42.11.1007675. Drugs Today (Barc). 2006. PMID: 17171192 Review.
Cited by
-
No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia.J Clin Psychopharmacol. 2013 Apr;33(2):226-30. doi: 10.1097/JCP.0b013e31828701d0. J Clin Psychopharmacol. 2013. PMID: 23422397 Free PMC article. Clinical Trial.
-
A semisynthetic Quillaja saponin as a drug delivery agent for aminoglycoside antibiotics.Pharm Res. 1995 Dec;12(12):1917-23. doi: 10.1023/a:1016235705448. Pharm Res. 1995. PMID: 8786966
-
Quercetin solid lipid microparticles: a flavonoid for inhalation lung delivery.Eur J Pharm Sci. 2013 May 13;49(2):278-85. doi: 10.1016/j.ejps.2013.03.009. Epub 2013 Mar 26. Eur J Pharm Sci. 2013. PMID: 23541500 Free PMC article.
-
Uptake of melatonin into the cerebrospinal fluid after nasal and intravenous delivery: studies in rats and comparison with a human study.Pharm Res. 2004 May;21(5):799-802. doi: 10.1023/b:pham.0000026431.55383.69. Pharm Res. 2004. PMID: 15180337
-
Intranasal insulin. Clinical pharmacokinetics.Clin Pharmacokinet. 1992 Jul;23(1):30-41. doi: 10.2165/00003088-199223010-00003. Clin Pharmacokinet. 1992. PMID: 1617857 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical